FRES
NASDAQ
$0.85
Fresh2 Group Limited (FRES)
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Diagnostics & Research
Market Cap
$2.97M
P/B Ratio
0.17
Beta (5Y)
0.01
Price Chart
Valuation
Market Cap$2.97M
P/S0.12
P/B0.17
Profitability
Total Revenue (TTM)$17M
EBITDA-$116M
Operating Margin-699%
EPS-$72.68
Growth & Risk
Beta (5Y)0.01
Sharpe Ratio-1.63